Chimeric Antigen Receptor T Cell Therapy For Solid Tumors.

Hsu J, Yang Y, Gergis M, Bi X, Yi D, Gergis U. Chimeric Antigen Receptor T Cell Therapy For Solid Tumors. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):94-99.

View in: PubMed

subject areas

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive
Neoplasms
Receptors, Antigen, T-Cell
T-Lymphocytes

authors with profiles

Usama Gergis

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement